Astroglial-derived protein S100B is known to play important roles in axonal growth, neural plasticity, and energy regulation. Disturbance of these neurodevelopmental processes is proposed as one possible etiology for mood disorder. Therefore, we performed a genetic analysis of S100B in patients with major depressive disorder (MDD).
Method:
The polymorphisms of S100B were determined by polymerase chain reaction–restriction fragment length polymorphism in patients (n = 152) with MDD and healthy control subjects (n = 150). The genotypic and allelic distributions of 2 variants were analyzed in Chinese patients.
Results:
Two single nucleotide polymorphisms did not display significant associations with MDD. However, there were significant differences in age of onset in 3 genotypes of S100B rs9722. Significant differences in the subgroup depression (first-episode and recurrent depression) were also shown in 3 genotypes of S100B rs9722 and rs11911834 in patients and control subjects (P < 0.05).
Conclusions:
Our findings did not suggest association of S100B gene polymorphisms in patients with MDD in China. We found there were differences in depressive episodes among different genotypes of S100B gene.
LevinsonDF. The genetics of depression: A review. Biol Psychiatry. 2006;60(2):84–92.
2.
SullivanPFNealeMCKendlerKS. Genetic epidemiology of major depression: Review and meta-analysis. Am J Psychiat. 2000;157(10):1552–1562.
3.
WenderPHKetySSRosenthalD, Psychiatric disorders in the biological and adoptive families of adopted individuals with affective disorders. Arch Gen Psychiatry. 1986;43(10):923–929.
4.
DonatoR.S100: A multigenic family of calcium-modulated proteins of the EF-hand type with intracellular and extracellular functional roles. Int J Biochem Cell Biol. 2001;33(7):637–668.
5.
DonatoR.Functional roles of S100 proteins calcium-binding proteins of the EF-hand type. Biochem Biophys Acta. 1999;1450(3):191–231.
6.
RothermundtMFalkaiPPonathG, Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry. 2004;9(10):897–899.
7.
AlloreRO'HanlonDPriceR, Gene encoding the beta-subunit of S100 protein is on chromosome 21: Implications for Down syndrome. Science. 1988;239(4845):1311–1313.
8.
AlloreRJFriendWCO'HanlonD, Cloning and expression of the human S100-beta gene. J Biol Chem. 1990;265(26):15537–15543.
9.
ValladaHCraddockNVasquesL, Linkage studies in bipolar affective disorder with markers on chromosome 21. J Affect Disord. 1996;41(3):217–221.
10.
StraubRELehnerTLuoY, A possible vulnerability locus for bipolar affective disorder on chromosome 2 lq22.3. Nature Genet. 1994;8(3):291–296.
11.
GurlingHSmythKKalsiG, Linkage findings in bipolar disorder. Nature Genet. 1995;10(1):8–9.
12.
Detera-WadleighSDBadnerJAYoshikawaT, Initial genome scan of the NIMH genetics initiative bipolar pedigrees chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am J Med Genet. 1997;74(3):254–262.
13.
EriksenJLDruseMJ. Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes. Brain Res. 2001;128(2):157–164.
14.
Whitaker-AzmitiaPMAzmitiaEC. Astroglial 5-HT1a receptors and S-100 beta in development and plasticity. Perspect Dev Neurobiol. 1994;2(3):233–238.
15.
SenJBelliA.S100B in neuropathologic states: The CRP of the brain?J Neurosci Res. 2007;85(7):1373–1380.
16.
NishiyamaHTakemuraMTakedaT, Normal development of serotonergic neurons in mice lacking S100B. Neurosci Lett. 2002;321(1–2): 49–52.
17.
PezetSMalcangioM.Brain-derived neurotrophic factor as a drug target for CNS disorders. Expert Opin Ther Targets. 2004;8(5):391–399.
18.
ManevHManevR.S100B an old neurotrophic factor with putative new roles in psychiatric illnesses. J Psychiatr Res. 2001;35(6):347–348.
19.
RothermundtMPetersMPrehnJH, S100B in brain damage and neurodegeneration. Microsc Res Tech. 2003;60(6):614–632.
20.
GrabeHJAhrensNRoseHJ, Neurotrophic factor S100 beta in major depression. Neuropsychobiology. 2001;44(2):88–90.
21.
RothermundtMAroltVWiesmannM, S100B is increased in melancholic but not in non-melancholic major depression. J Affect Disord. 2001;66(1):89–93.
22.
LiuJShiYTangJ, SNPs and haplotypes in the S100B gene reveal association with schizophrenia. Biochem Biophys Res Commun. 2005;328(1):335–341.
23.
RocheSCassidyFZhaoC, Candidate gene analysis of 21q22: Support for S100B as a susceptibility gene for bipolar affective disorder with psychosis. Am J Med Genet Neuropsychiatr Genet. 2007;144B(8):1094–1096.
24.
PangTJ, translator. Mood disorder. Diagnostic and statistical manual of mental disorders, 4th ed (Chinese). Xian (CH): Yangsen Lib; 2001. p 130–160.
25.
JonssonEGNothenMMGustavssonJP, Polymorphisms in the dopamine, serotonin, and norepinephrine transporter genes and their relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Psychiat Res. 1998;79(1):1–9.
26.
National Center for Bioltechnology Information. Entrez SNP (single nucleotide polymorphism) [Internet]. Bethesda (MD): National Library of Medicine; 2009 [cited date unknown]. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?CMD=search&DB=snp.
CohenJ.Statistical power analysis for the behavioralsciences. In: Anonymous, seconded. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
29.
YangKHuYQXieGR, No association of the rs9722 CT in the s100B gene and susceptibility to major depression in a Chinese population. Genet Test. 2008;12(4):487–489.
30.
WiesmannMMisslerUGottmannD, Plasma S100b protein concentration in healthy adults is age- and sex-independent. Clin Chem. 1998;44(5):1056–1058.
31.
ShengJGMrakRERovnaghiCR, Human brain S100 beta and S100 beta mRNA expression increases with age pathogenic implications for Alzheimer's disease. Neurobiol Aging. 1996;17(3):359–363.
FrankEKupferDJPerelJM, Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47(12):1093–1099.
35.
MuellerTILeonACKellerMB, Recurrence after recovery from major depressive disorder during 15 years of observational follow-up. Am J Psychiatry. 1999;156(7):1000–1006.
36.
PettitJWLewinsohnPMJoinerTEJr. Propagation of major depressive disorder relationship between first episode symptoms and recurrence. Psychiatr Res. 2006;141(3):271–278.
37.
AntonijevicIA. Depressive disorders—is it time to endorse different pathophysiologies?Psychoneuroendocrinology. 2006;31(1):1–15.
